cardiovascular system
|
• following ischemia/reperfusion injury
• however, knockdown of Bclaf1 via adenoviral expressing CRISPR-targeting Bclaf1 restores wild-type response
|
|
• following ischemia/reperfusion injury
• however, knockdown of Bclaf1 via adenoviral expressing CRISPR-targeting Bclaf1 restores wild-type response
|
homeostasis/metabolism
|
• following ischemia/reperfusion injury
• however, knockdown of Bclaf1 via adenoviral expressing CRISPR-targeting Bclaf1 restores wild-type response
|
|
• more than in control mice following ischemia/reperfusion injury
|
cellular
|
• following ischemia/reperfusion injury
• however, knockdown of Bclaf1 via adenoviral expressing CRISPR-targeting Bclaf1 restores wild-type response
|
muscle
|
• following ischemia/reperfusion injury
• however, knockdown of Bclaf1 via adenoviral expressing CRISPR-targeting Bclaf1 restores wild-type response
|
|
• following ischemia/reperfusion injury
• however, knockdown of Bclaf1 via adenoviral expressing CRISPR-targeting Bclaf1 restores wild-type response
|


Analysis Tools